Developers working on methicillin-resistant staphylococcus aureus (MRSA) treatments market are expected to invest resources into research and development activities, for the generation of new product ...

During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical ...

The company’s bacteriophage therapy AP-SA02 achieved an 88% response rate in a Phase 2a trial for Staphylococcus aureus ...

Scientists from Boston University’s College of Engineering have discovered a new optical microscopic technique using blue laser light which has the capability to weaken MRSA cells and potentially ...

MRSA (methicillin-resistant Staphylococcus aureus) is a well known superbug, a pathogenic microbe that can cause serious or fatal infections, which are resistant to treatment with standard antibiotics ...

"These in vivo data constitute an important finding that may have significant clinical implications for the management of many wound etiologies, such as burns, diabetic foot ulcers, venous leg ulcers, ...

Nanoengineers at the University of California, San Diego, have developed a potential treatment for skin and wound infections caused by methicillin-resistant Staphylococcus aureus. The treatment is a ...

Mathematical modeling suggests that the rate at which a patient's immune system clears slow-growing variants of methicillin-resistant Staphylococcus aureus (MRSA) bacteria is a key determinant of ...